1. Stress Urinary Incontinence in Women With Multiple Sclerosis. |
Page:224—231 |
2. Typical Value Ranges and Typical Signal Patterns in the Initial Cough in Patients With Neurogenic Bladder: Quality Control in Urodynamic Studies. |
Page:214—223 |
3. Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?. |
Page:209—213 |
4. Melatonin's Effect on the Efficacy of Desmopressin in the Treatment of Enuresis. |
Page:203—208 |
5. Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans. |
Page:197—202 |
6. The Early Histological Effects of Intravesical Instillation of Platelet-Rich Plasma in Cystitis Models. |
Page:188—196 |
7. Controls of Nuclear Factor-Kappa B Signaling Activity by 5’-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells. |
Page:182—187 |
8. Application of Virtual, Augmented, and Mixed Reality to Urology. |
Page:172—181 |
9. Role of 5´-AMP-Activated Protein Kinase Activators in Regulating Nuclear Factor Kappa B Signaling. |
Page:171—171 |
10. The Potential Application of Virtual, Augmented, and Mixed Reality in Neurourology. |
Page:169—170 |
11. Sacral Neuromodulation in Patients With a Cardiac Pacemaker. |
Page:270—272 |
12. Foreign Bodies in the Urinary Bladder and Their Management: A Single-Centre Experience From North India. |
Page:260—269 |
13. Translation and Linguistic Validation of the Korean Version of the "Benefit, Satisfaction, and Willingness to Continue" Questionnaire for Patients With Overactive Bladder. |
Page:255—259 |
14. Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique. |
Page:250—254 |
15. Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms. |
Page:240—249 |
16. Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients. |
Page:232—239 |